These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 18004150)

  • 41. Hyperammonemia induced by interaction of valproate and quetiapine.
    Halaby A; Haddad R; Naja WJ
    Curr Drug Saf; 2013 Sep; 8(4):284-6. PubMed ID: 23962184
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Eficcacy of extended release quetiapine in affective symptoms.
    Alamo C; López-Muñoz F
    Rev Psiquiatr Salud Ment; 2012; 5 Suppl 1():3-19. PubMed ID: 23265762
    [No Abstract]   [Full Text] [Related]  

  • 43. Pharmacokinetics and elimination of quetiapine, venlafaxine, and trazodone during pregnancy and postpartum.
    Klier CM; Mossaheb N; Saria A; Schloegelhofer M; Zernig G
    J Clin Psychopharmacol; 2007 Dec; 27(6):720-2. PubMed ID: 18004149
    [No Abstract]   [Full Text] [Related]  

  • 44. Quetiapine in management of manic symptoms in patient with heart transplantation: a case report.
    Franić T; Kero T; Katić J; Marčinko D; Bilušić M
    Psychiatr Danub; 2012 Dec; 24(4):402-4. PubMed ID: 23132193
    [No Abstract]   [Full Text] [Related]  

  • 45. Health-related quality of life in adolescents with bipolar I disorder.
    Rademacher J; DelBello MP; Adler C; Stanford K; Strakowski SM
    J Child Adolesc Psychopharmacol; 2007 Feb; 17(1):97-103. PubMed ID: 17343557
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Quetiapine-induced leucopenia and thrombocytopenia.
    Shankar BR
    Psychosomatics; 2007; 48(6):530-1. PubMed ID: 18071101
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The effectiveness of high-dosage amisulpride combined with moderate-dosage sodium valproate treatment for an overweight patient with psychotic bipolar disorder.
    Hou YC; Lai CH
    J Neuropsychiatry Clin Neurosci; 2014 Apr; 26(2):E34-5. PubMed ID: 24763785
    [No Abstract]   [Full Text] [Related]  

  • 48. Cognitive effects of quetiapine XR in patients with euthymic bipolar disorder.
    Rakofsky JJ; Dunlop BW; Beyer JL; Oliver AM; Mansson EE; Sancheti MT; Harvey PD
    J Clin Psychopharmacol; 2014 Jun; 34(3):383-5. PubMed ID: 24717252
    [No Abstract]   [Full Text] [Related]  

  • 49. Professional consensus on the treatment of agitation, aggressive behaviour, oppositional behaviour and psychotic disturbances in dementia.
    Benoit M; Arbus C; Blanchard F; Camus V; Cerase V; Clement JP; Fremont P; Guerin O; Hazif Thomas C; Jeanblanc F; Lafont C; Moreaud O; Pedra M; Poncet M; Richard Harston S; Rigaud AS; Sotto Martin ME; Touchon J; Vellas B; Fitten LJ; Robert PH
    J Nutr Health Aging; 2006; 10(5):410-5. PubMed ID: 17066213
    [No Abstract]   [Full Text] [Related]  

  • 50. Valproic acid for dysphoric mania in a mentally retarded adolescent.
    Whittier MC; West SA; Galli VB; Raute NJ
    J Clin Psychiatry; 1995 Dec; 56(12):590-1. PubMed ID: 8530338
    [No Abstract]   [Full Text] [Related]  

  • 51. Treatment of bulimia and rapid-cycling bipolar disorder with sodium valproate: a case report.
    Herridge PL; Pope HG
    J Clin Psychopharmacol; 1985 Aug; 5(4):229-30. PubMed ID: 3926833
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Patterns of quetiapine use in psychiatric inpatients: an examination of off-label use.
    Philip NS; Mello K; Carpenter LL; Tyrka AR; Price LH
    Ann Clin Psychiatry; 2008; 20(1):15-20. PubMed ID: 18297582
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Off-label prescription of quetiapine in psychiatric disorders.
    Rowe DL
    Expert Rev Neurother; 2007 Jul; 7(7):841-52. PubMed ID: 17610391
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A 12-week, open, randomized trial comparing sodium valproate to lithium in patients with bipolar I disorder suffering from a manic episode.
    Bowden C; Göğüş A; Grunze H; Häggström L; Rybakowski J; Vieta E
    Int Clin Psychopharmacol; 2008 Sep; 23(5):254-62. PubMed ID: 18703934
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Monotherapy versus combined treatment with second-generation antipsychotics in bipolar disorder.
    Ketter TA
    J Clin Psychiatry; 2008; 69 Suppl 5():9-15. PubMed ID: 19265635
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Comparative clinical responses to risperidone and divalproex in patients with pediatric bipolar disorder.
    MacMillan CM; Withney JE; Korndörfer SR; Tilley CA; Mrakotsky C; Gonzalez-Heydrich JM
    J Psychiatr Pract; 2008 May; 14(3):160-9. PubMed ID: 18520785
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Quetiapine for treatment-resistant mania.
    Dunayevich E; Strakowski SM
    Am J Psychiatry; 2000 Aug; 157(8):1341. PubMed ID: 10910805
    [No Abstract]   [Full Text] [Related]  

  • 58. Quetiapine-induced rabbit syndrome in a patient with bipolar disorder.
    Wu CC; Su KP
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):2002-3. PubMed ID: 18809453
    [No Abstract]   [Full Text] [Related]  

  • 59. [Quetiapin in bipolar disorders].
    Sümegi A
    Neuropsychopharmacol Hung; 2008 Dec; 10(5):281-91. PubMed ID: 19419014
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Valproate in the treatment of behavioral agitation in elderly patients with dementia.
    Lott AD; McElroy SL; Keys MA
    J Neuropsychiatry Clin Neurosci; 1995; 7(3):314-9. PubMed ID: 7580190
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.